Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million up Front and $280 Million in Biobucks 글 내용 전체보기
One Busy Week for AbbVie: Hepatitis C, Fibroids, Alzheimer’s & Parkinson’s, and Generic Criticism 글 내용 전체보기